Clinical Trials in New York

Showing 7641-7660 of 22,668 trials

Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty

NCT06333522

The purpose of this study is to determine the effect of Losartan, an Angiotensin II Receptor Blocker (ARB), on the formation development of arthrofibrosis in patients who have had a primary total knee arthroplasty. This study aims to assess the post-operative range of motion and the incidence of MUA within three months following the index arthroplasty in the treatment arm (losartan) and the control arm.

Arthrofibrosis of Knee

NYU Langone HealthStarted Jul 2024

New York, New York, United States

COMPLETED< 1 mile

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

NCT05858450

This study intends to describe the characteristics of patients given the Pfizer-BioNTech bivalent mRNA COVID-19 vaccine and any commercially available influenza vaccines at the same time versus at different times.

Influenza, HumanCOVID-19

Pfizer3,442,996 participantsStarted May 2023

New York, New York, United States

COMPLETED< 1 mile

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

NCT05775549

This study will collect the data from existing patient medical records at US cancer centers. The study will include patients with BRCAwt ovarian cancer who have been prescribed first line (1L) olaparib maintenance treatment.

Advanced Ovarian Cancer

AstraZeneca24 participantsStarted Jul 2023

Tampa, Florida, United States • Shreveport, Louisiana, United States • Annapolis, Maryland, United States +4 more locations

Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

Find Trials by Condition in New York

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

CLEAR SYNERGY Neutrophil Substudy

Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients

Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

An Open Label Study of IgG Fc Glycan Composition in Human Immunity

Testing Two Models of PrEP Delivery in OBGYN Clinics

Palbociclib in Real World Practice

Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects.

Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

Health Outcomes of Parents With Cystic Fibrosis

Clinical Trial Comparing C-Brace to Knee Ankle Foot Orthosis (KAFO)/Stance Control Orthosis (SCO)

A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma

Target Controlled Infusion Using Propofol and Remifentanil for Moderate Sedation in Dentistry